Tag Archives: stocks

Find Businesses That Control Their Destinies

By Frank Caruso, James T. Tierney, Jr. In a volatile world, it often feels like companies are subject to forces beyond their control. Finding companies that can steer their own course is a good way to capture resilient growth through changing market conditions. Not all companies are equally vulnerable to unpredictable market forces. Some exercise a much greater degree of control over their fate by virtue of having fundamentally sounder businesses based on stronger people, better products, superior operating execution and more responsible financial behavior. Searching for companies that command their destinies is one of several ways that active investors can capture excess returns over long time horizons. Balance Sheets Matter Balance sheet health – and low earnings volatility – is a great indicator of resilience. Investors should always scrutinize a company’s balance sheet, but in times of stress, this is even more important. Companies with less debt to service will pay less of a penalty in their financing costs when interest rates rise. Low debt ratios also are good indicators of a company’s flexibility to execute its strategy without relying on banks or credit markets. And businesses that can generate the cash they need to fund and invest in their operations are less beholden to the demands of externally sourced capital, and less vulnerable to a potential tightening of credit markets. Solid balance sheets and sustainable sources of growth are a winning combination. Companies with both are much better equipped to reward shareholders by increasing their dividends or buying back shares – even in tough market conditions. Companies in the top quintile of share repurchases – especially those with attractive valuations – have outperformed the market historically ( Display ). Click to enlarge Focus on Pricing Power Pricing power is another indicator of a company’s ability to deliver sustainable growth. With China and emerging markets slowing down, and with anemic recoveries in countries from the US to Europe, it’s difficult to find sources of new demand. And with inflation stuck at very low levels, it’s not easy for companies to raise prices. So companies that demonstrate pricing power in their industries are better positioned to improve their earnings than are their competitors that lack it. We think there are three keys to pricing power: innovation, competition and cost and inflation dynamics. Innovative products and services are capable of commanding higher prices even in a tough economy and amid low inflation. For example, Apple (NASDAQ: AAPL ) commands premium prices for its smartphones because of its innovative features and an ecosystem that allows all the company’s devices to work together seamlessly. A highly competitive environment makes it much more difficult for companies to raise prices. And in a low-inflation world, cost dynamics are crucial. Given this reality, we believe that companies with strong market positions and relatively fixed cost businesses are better placed to increase revenues while leveraging costs. For example, Visa (NYSE: V ) and MasterCard (NYSE: MA ) are the two largest global card networks. As such, they have had the ability to modestly increase prices over time while competitors have seen price erosion. And the nature of their networks means that additional transactions or volumes are highly profitable from an incremental margin perspective. Understanding these dynamics can help underpin an investing plan for an unpredictable world. Investors in passive equity portfolios may be more exposed to capricious market forces because they will hold many benchmark stocks that are more vulnerable to instability. In contrast, in our view, active equity managers can target companies with clear advantages in confronting erratic headwinds – and controlling their destinies – which can lead to resilient long-term returns. The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams. Frank Caruso, CFA, Chief Investment Officer – US Growth Equities James T. Tierney, Jr., Chief Investment Officer – Concentrated US Growth

Ollie’s Bargain Outlet Leads Discount Retail Chain Stocks

The rally that began in February has disappointed growth stock investors. Their best names have done little. But one group that stands out is the discount retailers. The industry group is ranked No. 6, rising from No. 43 three months ago. It’s up 17.4% year to date as of Tuesday’s IBD. That’s in contrast to a 2.2% decline for the Nasdaq and a 2.1% gain for the S&P 500. The group has only five companies, all within 6% of 52-week highs. Their strength might be evidence of a desire by money managers to invest in consumer-oriented firms that are still growing amid a soft economy and declining earnings in other sectors. The star of the group is new issue Ollie’s Bargain Outlet ( OLLI ). It broke out of a cup-with-handle base, which was also an IPO base, with a 22.63 buy point March 18. After sputtering for a couple of weeks, it rose sharply, slicing through the profit-taking zone between 20% and 25%. It’s now consolidating in that zone. The company operates what it describes as 207 “semi-lovely” stores, mostly in Eastern states, that sell closeouts, excess inventory, bankruptcies and last year’s colors, patterns and packaging. If your area has had a flood, fire or earthquake, you might find undamaged goods bought from insurance companies. Prices can be up to 70% off. The company wants to grow to 950 stores. Another strong stock in the rally is Five Below ( FIVE ), which caters to teens and tweens with cellphone accessories, toys, casual apparel, sports gear, candy and seasonal items, all costing under $5. It’s been a volatile stock, but the fundamentals have been solid. Last week, Credit Suisse issued a report calling Five Below “one of the most attractive growth stories in retail.” It operates 437 stores but plans to grow to four or five times that many. The five-year annualized EPS growth rate is 45%, although earnings have slowed some in recent quarters. Analysts expect 24% growth this year and 22% in 2017. Dollar General ( DG ) gapped out of a cup-with-handle base with a 76.85 buy point after reporting an 11% increase in fiscal Q4 earnings on March 10. After encouraging investors with a run-up after that, it has pulled back and found support at its 50-day moving average. The pullback came in generally light volume, and the day it found support, April 22, volume was higher, but the stock finished more than 40% off the low of the day. That constitutes bullish action. Two other stocks in the group, Big Lots ( BIG ) and Dollar Tree ( DLTR ), also deserve a look. Big Lots broke out of cup-with-handle base with a 46.23 buy point on April 13 in below-average trade, but volume picked up sharply as the stock rallied nearly 2% to 47.68 in heavy trading. The stock remains in the 5% buy zone. It reported a 14% earnings increase in the last report, slightly above estimates. Dollar Tree has been moving in a narrow trading range for most of this year. Earnings per share have declined vs. year-earlier levels for three straight quarters but are expected to rise 14% in the next report to 81 cents.

Edwards Lifesciences Q1 Earnings Beat Estimates; Guidance Raised

Medical-device maker and IBD 50 stock Edwards Lifesciences ( EW ) beat analysts’ Q1 estimates and raised guidance late Tuesday, sending the stock up a fraction in after-hours trading. Edwards made 71 cents a share in the quarter, excluding one-time items, up 25% from the year-earlier quarter and topping analysts’ consensus of 66 cents, according to Thomson Reuters. Sales rose 18% to $697 million, vs. consensus of $665 million. Edwards lifted its full-year earnings guidance to $2.67 to $2.77, a dime above the guidance it issued in its Q4 report. It added around $100 million to its sales range, now $2.7 billion to $3 billion. Is Edwards Lifesciences past its buy point? Try Leaderboard and find out Edwards also guided Q2 above expectations, with EPS of 67 to 73 cents and sales of $700 million to $740 million. For Q2, analysts expected earnings of 67 cents a share and sales of $698 million. Edwards stock has been on a roll this year, hitting a record high of 109.71 in Tuesday’s regular session before closing up a fraction, at 108.84. This month, the company’s Sapien 3 transcatheter aortic valve replacement was shown to reduce deaths from heart attacks  in patients with at moderate risk from open-heart surgery, boosting its stock 17% on April 4. With an IBD Composite Rating of 97, it’s currently No. 8 on the IBD 50 list of top-performing stocks over the past 12 months.